Acute chest syndrome (ACS) is a serious lung complication of sickle cell disease that occurs when sickled red blood cells block blood vessels in the lungs, causing pain, breathing difficulty, and new abnormalities on a chest X-ray. It is one of the leading causes of death in people with sickle cell disease, accounting for roughly 26% of deaths in one large multi-center study. ACS can develop on its own or emerge during a pain crisis that’s already underway, and it requires prompt hospital treatment.
What Happens in the Lungs
In sickle cell disease, red blood cells become rigid and crescent-shaped, which makes them prone to clumping together and getting stuck in small blood vessels. When this happens in the lungs, it triggers a chain of events that damages lung tissue. The blocked blood flow can cause areas of the lung to lose oxygen supply, leading to inflammation and fluid buildup that makes breathing harder.
The triggers differ somewhat between adults and children. In adults, the primary culprit is fat or bone marrow emboli. During a pain crisis, bone marrow can release small fat particles into the bloodstream. These travel to the lungs, where they break down into fatty acids that are highly inflammatory, injuring the delicate lung tissue and dropping oxygen levels. In children, infection is the more common trigger. About 40% of pediatric ACS cases can be traced to a specific cause, and among those, roughly 40% involve infections, most often viral infections or certain types of bacterial pneumonia. Other triggers in both age groups include asthma flare-ups, low oxygen levels, complications after surgery, and oversedation from pain medications.
Symptoms to Recognize
ACS symptoms overlap heavily with pneumonia, which is part of what makes it dangerous. According to the CDC, the hallmark signs include chest pain, coughing, difficulty breathing, and fever. What makes ACS tricky is that it often develops while someone is already hospitalized for a pain crisis. A person might come in with severe bone or joint pain, and then over the next day or two, develop a new cough, worsening chest pain, or a fever that wasn’t there before.
The key distinction from a routine pain crisis is the respiratory component. If breathing becomes labored, oxygen levels start dropping, or a new infiltrate (a cloudy area indicating fluid or inflammation) appears on a chest X-ray, the diagnosis shifts to ACS. This is why hospital staff closely monitor breathing and oxygen levels in anyone admitted for a sickle cell pain crisis.
How ACS Is Treated
Treatment depends on severity and can range from supportive care to urgent blood transfusions. On the milder end, the focus is on maintaining oxygen levels, managing pain carefully (since both undertreating and overtreating pain can worsen the situation), giving fluids, and treating any underlying infection with antibiotics.
When ACS is more serious, blood transfusions become necessary. A simple transfusion, which adds healthy red blood cells to raise hemoglobin to around 10 to 11 g/dL, is typically considered when hemoglobin drops significantly below a person’s baseline or when oxygen levels can’t stay above 92% on room air. For severe cases, where oxygen keeps dropping, breathing rate climbs, platelet counts fall, or the chest X-ray shows disease spreading across multiple areas of the lung, a red cell exchange transfusion may be needed. This procedure removes sickled cells and replaces them with healthy donor cells, and it can turn things around quickly in a deteriorating patient.
Deep breathing exercises using a device called an incentive spirometer are commonly recommended during pain crises and ACS episodes. The standard approach involves taking 10 deep breaths with the device every two hours while awake. One study found an 87% reduction in ACS risk with this practice, though other research has been less conclusive. The overall evidence is still uncertain, but incentive spirometry is low-risk and remains a standard part of care in most hospitals.
Long-Term Effects on the Lungs
A single episode of ACS usually resolves fully with treatment. The concern is with repeated episodes. People who experience ACS multiple times can develop scattered areas of scarring in their lungs, particularly at the base. This condition, sometimes called sickle cell chronic lung disease, leads to measurable changes in lung function over time.
In the largest historical study of lung function in sickle cell patients, 90% had some abnormality on pulmonary function testing. The most common finding was a mild restrictive pattern, meaning the lungs couldn’t expand as fully as expected, along with a reduced ability to transfer oxygen from the lungs into the bloodstream. Average lung capacity measures like FEV1 and FVC, while technically in the normal range, clustered at the low end (around 83-84% of predicted values). True obstructive lung disease, the pattern seen in conditions like COPD, was uncommon, affecting only about 3% of adult patients. Advanced scarring severe enough to show up clearly on imaging is relatively rare, but subtle lung damage from repeated episodes accumulates over years.
Preventing ACS Episodes
The most effective prevention strategy is hydroxyurea, a daily medication that increases the production of fetal hemoglobin, a form that resists sickling. The results can be dramatic. In one study evaluating hydroxyurea’s impact, 11.1% of patients had experienced ACS before starting the medication, and after treatment, none had further episodes. Hydroxyurea also significantly reduces the frequency of pain crises, which are themselves a major risk factor for developing ACS.
Beyond medication, practical steps matter. Staying well-hydrated, avoiding extreme cold, treating asthma aggressively if present, and using incentive spirometry during any hospitalization all help reduce risk. For people undergoing surgery, the period immediately afterward is a known high-risk window for ACS, so surgical teams typically plan transfusions and close respiratory monitoring in advance. Recognizing the early signs of ACS, particularly new respiratory symptoms during a pain crisis, and getting to the hospital quickly can make the difference between a manageable episode and a life-threatening one.